Anaplastic lymphoma kinase inhibitor crizotinib, which induces AKI via tubulointerstitial damage, is only partly curable by stopping the treatment.[121] Since this is a developing field, doctors should be aware of medication toxicity in patients with unexplained AKI and consider doing a kidney biopsy to guide them for further actions. The gene discussed is ALK; the disease is acute kidney injury.